COMPOUND PROFILE / SMALL MOLECULES
Tesofensine.
Research draftTesofensine is a small-molecule monoamine reuptake inhibitor investigated for obesity.
Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.
Targeted source and identity review, not a systematic review or complete regulatory audit.
Overview
Tesofensine is a small-molecule monoamine reuptake inhibitor investigated for obesity.
Mechanism
It affects noradrenaline, dopamine and serotonin signalling.
Human research
A randomised oral obesity trial reported weight effects; this does not establish benefit-risk for unsupervised use.
Preclinical & other research
Animal and neurochemical work informed the appetite rationale.
Safety & unknowns
Heart rate, blood pressure, sleep and other monoamine-related effects are important.
Regulatory status
Authorisation must be checked by jurisdiction and product; no US or UK indication is established here.
Reported use & evidence
The supplied Tesofensine profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.
Sources & references
Follow the cited records and registered research. Profiles remain research drafts.